METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS

The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the J...

Full description

Saved in:
Bibliographic Details
Main Authors ROBINSON, Anne M, OTHMAN, Ahmed A, KLÜNDER, Ben, Machado de LACERDA, Ana Paula, JUNGERWIRTH, Steven, PANGAN, Aileen L, MOHAMED, Mohamed-Eslam F, ENEJOSA, Jose Jeffrey V, THAKKAR, Roopal B
Format Patent
LanguageEnglish
Published 14.02.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the JAK1 inhibitor to induce clinical remission and/or endoscopic improvement of the Crohn's disease, followed by administration of at least one maintenance dose of the JAK1 inhibitor thereafter. In other embodiments, the present disclosure is directed to methods for treating ulcerative colitis using a JAK1 inhibitor.
Bibliography:Application Number: US201815917013